An underground market for unapproved slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Separately, a flourishing market exists on Telegram, where communities with numerous of participants share “before and after” images, injection guides and assertions of next-day British shipping. Sellers market the substance there before redirecting customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Professionals Express Concerns
However, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.
Some experts said the popularity for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and customer laws, risking fines, legal action or imprisonment.
Platform Response and Content Removal
According to the social media company, the platform has taken down problematic material and banned related keywords and search suggestions. The organization said it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.
Digital Trading Operations
Investigations also found communities with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of members, populated with photos of weight loss, positive reviews and detailed instructions for mixing or injecting at residence.
Within moments of joining one community, a vendor posted contact information, where most purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.
Item Details and Costs
Within these groups, posts display black plastic packages with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When asked how long a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram said it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting materials they can’t verify. Even if the science behind this drug is sound, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.
Her team has previously seen patients harmed by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose patients to potentially significant medical dangers”.
